COMMUNIQUÉS West-GlobeNewswire

Oncology Venture Announces Abstracts on Three Pipeline Products Selected for 2018 ASCO Clinical Meeting

16/05/2018 - 23:00

Phase 1 Study of PARP Inhibitor 2X-121 Selected as Oral Presentation June 1, 2018 HOERSHOLM, Denmark and CAMBRIDGE, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Oncology Venture AB (OV:ST) (“OV” or the “Company”) announced [...]

Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018

16/05/2018 - 23:00

ASCO Posters to Feature Data on MT-3724 and Evofosfamide AUSTIN, Texas, May 16, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and [...]

Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting

16/05/2018 - 23:00

CALGARY, Alberta and SAN DIEGO, May 16, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]

Ziopharm Oncology to Present Data from Clinical Studies of Controlled IL-12 in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting

16/05/2018 - 23:00

- Data from biopsies shows Ad-RTS-hIL-12 plus veledimex recruits killer T cells into breast and brain cancers - IL-12 continues to demonstrate activity as a single-agent therapy, prolongs survival in patients with [...]

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Cannabidiol Oral Solution in Lennox-Gastaut Syndrome

16/05/2018 - 23:00

– First dose-ranging study comparing pharmaceutical formulation of cannabidiol to placebo as add-on therapy in Lennox-Gastaut syndrome, a rare, severe and difficult to treat form of childhood-onset epilepsy – – Both [...]

Clearside Biomedical to Present at the 2018 UBS Global Health Care Conference

16/05/2018 - 22:30

ALPHARETTA, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]

Ascendis Pharma A/S Announces First Quarter 2018 Financial Results and Business Update Conference Call on May 30

16/05/2018 - 22:20

COPENHAGEN, Denmark, May 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

16/05/2018 - 22:10

EAGAN, Minn., May 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29. Biothera [...]

Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting

16/05/2018 - 22:05

Highlighting Interim Data from Phase 1/2 Clinical Trial of FCX-007 Gene Therapy Candidate for Recessive Dystrophic Epidermolysis Bullosa EXTON, Pa., May 16, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC [...]

Adherium Launches the Hailie™ Global Brand to Connect People with Asthma and COPD to Better Care

16/05/2018 - 21:00

SAN MATEO, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced the launch of the [...]

CORRECTING AND REPLACING: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update

16/05/2018 - 20:19

ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Hemispherx Biopharma, Inc. (NYSE American:HEB) with the same headline, the net loss from operations was incorrect in the fourth [...]

Aquinox to Present at 2018 UBS Global Healthcare Conference

16/05/2018 - 19:32

VANCOUVER, British Columbia, May 16, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]

NeuroSearch and Teva Pharmaceutical International enter into agreement on outstanding obligations

16/05/2018 - 19:22

Announcement 16 May 2018 NeuroSearch has today entered into an agreement with, among others, Teva Pharmaceutical International GmbH (Teva), to release Teva from all outstanding obligations pursuant to the agreement from [...]

HEALTH FOUNDATION OF SOUTH FLORIDA AWARDS GRANTS TO FIVE LOCAL ORGANIZATIONS TOTALING $458,824

16/05/2018 - 18:56

The combined impact of the funding is expected to reach and improve health for thousands of residents MIAMI,FL-, May 16, 2018 (GLOBE NEWSWIRE) -- Health Foundation of South Florida’s Board of Directors recently approved [...]

CROSSJECT : Point d'activité mai 2018

16/05/2018 - 18:28

Communiqué de Presse Point d'activité mai 2018 Nouvelle étape dans l'industrialisation Négociations commerciales en bonne voie Confirmation de l'objectif de dépôts de demande d'AMM [1] Dijon, le 16 mai 2018 CROSSJECT ( [...]

Cesca Prices $5.5 Million Public Offering

16/05/2018 - 18:00

RANCHO CORDOVA, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the [...]

Notification from Oasmia Pharmaceutical

16/05/2018 - 18:00

Oasmia Pharmaceutical AB (publ) hereby notify that the Company, Arwidsro Investment and MGC Capital have agreed to extend the payment of the loan, which was communicated January 2 nd until September 30 th . The reason [...]

Bavarian Nordic to Host First Quarter 2018 Results Conference Call

16/05/2018 - 17:31

COPENHAGEN, Denmark - May 16 , 201 8 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2018 first quarter results on Thursday, May 24, 2018. The management of Bavarian Nordic will host a conference call at [...]

Theratechnologies Provides Update on Trogarzo™ (Ibalizumab-Uiyk) Injection Prescriptions and Reimbursement Status

16/05/2018 - 17:30

MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) today disclosed, during its annual meeting, information on the number of scripts and reimbursement coverage for Trogarzo™ in the United States [...]